Patents
Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
10/2010
10/05/2010US7807708 retinoic acid receptor modulators such as ethyl 3''-tert-butyl-4''-diethylamino-4'-hydroxy[1,1';3',1'']terphenyl-4-carboxylate, used for for preventing and/or treating the signs of aging and/or dry sun
10/05/2010US7807697 Disorders related to memory and cognition processes, neurological processes, cardiovascular function, and body weight; benzoxazole, benzimidazole, and indole compounds substituted with pyrrole, azepane, piperidine or azetidine e.g. 4-{2-[2-(2-methyl-pyrrolidin-1-yl)-ethyl]-benzooxazol-5-yl}-benzonitrile
10/05/2010US7807693 e.g. 4-methoxy-pyrrolidine-1,2-dicarboxylic acid-1-[(4-chloro-phenyl)-amide]-2-(2-methyl-1,2,3,4-tetrahydro-isoquinolin-7-yl)-amide; factor Xa and related serine proteases inhibitor; anticoagulant, thrombolytic agent
10/05/2010US7807691 [4-(3-Methoxy-phenyl)-4-oxo-butyl]-carbamic acid tert-butyl ester; Age related functional decline, osteoporosis, osteopenia, bone fractures, male and female sexual dysfunction, erectile dysfunction, depression, prostate cancer, decreased cognitive ability, or lethargy
10/05/2010US7807678 Peptidomimetics of biologically active metallopeptides
10/05/2010US7807669 Peroxisome proliferator-activated receptor type gamma (PPAR- gamma) modulators such as (S)-3-{3'-[(benzoylmethylamino)methyl]biphenyl-4-yl}-2-(1-methyl-3-oxo-3-phenylpropenylamino)propionic acid, suited for use in dermatology, immunology, cardiovascular diseases and/or hyperlipemia
09/2010
09/30/2010WO2010110440A1 Novel therapeutic agent for cognitive impairment
09/30/2010WO2010108902A1 1,1,1-trifluoro-2-hydroxypropyl compounds
09/30/2010US20100249434 Method for the vinylation of amides
09/30/2010US20100249422 Acylation reaction of hydroxyl group
09/30/2010US20100249350 Hyperbranched polymer having nitroxyl group
09/30/2010US20100249276 Curatives for epoxy compositions
09/30/2010US20100249207 Synthesis of pyrrolidine compounds
09/30/2010US20100249197 Carbamic acid compounds comprising an amide linkage as hdac inhibitors
09/30/2010US20100249101 Malonamide derivatives with antithrombotic activity
09/30/2010US20100249086 Compounds As Cannabinoid Receptor Ligands
09/30/2010US20100249075 Substituted tetralins as selective estrogen receptor-beta agonists
09/30/2010US20100249049 Arylalkylamine compound and process for preparing the same
09/30/2010US20100249001 Amine-terminated telechelic polymers and precursors thereto and methods for their preparation
09/30/2010US20100248355 Methods for generating high titer helper-free preparations of released recombinant aav vectors
09/30/2010US20100248264 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions
09/30/2010US20100248261 Method to determine protein interaction sites
09/30/2010US20100247658 Organic compounds
09/30/2010US20100247471 Phenoxy-pyrrolidine derivative and its use and compositions
09/30/2010US20100247454 Compositions for elastogenesis and connective tissue treatment
09/30/2010CA2756152A1 9h-pyrrolo[2,3-b: 5,4-c'] dipyridine azacarboline derivatives, preparation thereof, and therapeutic use thereof
09/30/2010CA2754416A1 Novel medicament for treating cognitive impairment
09/30/2010CA2754184A1 1,1,1-trifluoro-2-hydroxypropyl compounds
09/29/2010EP2233469A1 Method for coupling halogen-substituted aromatic substances with trialkylsilyl-substituted heteroatom-containing organic compounds
09/29/2010EP2231659A1 Translocator protein ligands
09/29/2010EP1893200B1 Carbamate derivatives as positive allosteric modulators of metabotropic glutamate receptors
09/29/2010EP1628957B1 Sulfopyrroles
09/29/2010CN1867580B Compound modified with glycerol derivative
09/29/2010CN1794987B Nitrooxyderivatives of fluvastatin, pravastatin, cerivastatin, atorvastatin and rosuvastatin as cholesterol-reducing agents with improved anti-inflammatory, antithrombotic and antiplatelet activity
09/29/2010CN101848905A Process for the enantioselective preparation of pregabalin
09/29/2010CN101847479A Microwave composite material and preparation method thereof
09/29/2010CN101845009A Structural carotenoid analogs for the inhibition and amelioration of disease
09/28/2010US7803954 Mandelic acid derivatives and their use as thrombin inhibitors
09/28/2010US7803819 dipeptidyl peptidase IV (DPP-IV) inhibitors, such as 2S)-1-{[(1S)-2-(5-cyano-2-methyl-indol-1-yl)-1-methyl-ethylamino]-acetyl}-pyrrolidine-2-carbonitrile, useful for the treatment and/or prophylaxis non-insulin dependent diabetes and impaired glucose tolerance; antidiabetic agents
09/23/2010WO2010107487A2 Lipid-drug conjugates for drug delivery
09/23/2010WO2010107384A1 Aspartyl protease inhibitors
09/23/2010WO2010106078A1 Method for coupling halogen-substituted aromatic compounds with organic compounds comprising trialkylsilyl-substituted heteroatoms
09/23/2010WO2010105930A1 Carbamate derivatives in particular for the treatment of neurological disorders
09/23/2010WO2010105367A1 Processes for preparing amino-substituted gamma-lactams
09/23/2010WO2010087419A3 Cyclopropanecarboxylic acid ester derivatives and their use as pest control agents
09/23/2010WO2010059639A3 Hydroxyadamantyl inhibitors of dipeptidylpeptidase iv
09/23/2010US20100240924 2-ethyl-4,6-dimethyl-phenyl-substituted tetramic acid derivatives as pest control agents and/or herbicides
09/23/2010US20100240883 Lipid-drug conjugates for drug delivery
09/23/2010US20100240728 Co-Crystals of Pyrrolidinones
09/23/2010US20100240653 Biphenyl sulfonyl and phenyl-heteroaryl sulfonyl modulators of the histamine h3-receptor useful for the treatment of disorders related thereto
09/23/2010US20100240639 Sulfonyl-Derivatives as Novel or Histone Deacetylase
09/23/2010US20100236321 Means and method for predicting diabetes
09/22/2010EP2230230A1 Substituted dihydroazole compound and pest control agent
09/22/2010EP2229935A1 Peptide derivatives or pharmaceutically acceptable salts thereof, method for producing the same, use of said derivatives and pharmaceutical composition
09/22/2010EP2229357A1 Method for producing n-vinyl pyrrolidone from lactone-free pyrrolidone
09/22/2010EP2229356A1 1,2-disubstituted-4-benzylamino-pyrrolidine derivatives as cetp inhibitors useful for the treatment of diseases such as hyperli pidemia or arteriosclerosis
09/22/2010EP1836163B1 Pyrrolidine derivatives for the treatment of a disease depending on the activity of renin
09/22/2010EP1786766B1 Compounds which potentiate glutamate receptor and uses thereof in medicine
09/22/2010CN1780813B Acid generators, sulfonic acids, sulfonyl halides, and radiation-sensitive resin compositions
09/22/2010CN101842350A New non-peptide derivatives as bradykinin Bl antagonists
09/22/2010CN101838260A Dihydropyrrolones derivative as Caspase-3 inhibitor
09/21/2010US7799932 nontoxic reagents, cost effective route to monomers for poly(3,4-alkylenedioxypyrroles) which are useful in electrochromic windows, mirrors and displays, electronic paper, conductors, field effect transistors, supercapacitors, batteries, and photovoltaic devices
09/21/2010US7799924 Substituted homopiperidine, piperidine or pyrrolidine derivatives
09/21/2010US7799828 selective estrogen receptor modulators such as 4-[(4-Hydroxyphenyl)(3,3,5,5-tetramethylcyclohexylidene)methyl]benzoic acid, used for the treatment of osteoporosis, obesity, breast cancer, depression, vaginal dryness, rheumatoid arthritis, vasomotor symptoms and urogenital or vulvar vaginal atrophy
09/21/2010US7799823 Androgen modulators
09/21/2010US7799819 chronic lymphocytic leukemia or acute lymphoblastic leukemia; use of specific compound (1R)-cyclopropanecarboxylic acid {2-[2-carbamoyl-1-(3-ethoxy-4-methoxy-phenyl)-ethyl]-7-chloro-3-oxo-2,3-dihydro-1H-isoindol-4-yl}-amide
09/21/2010US7799576 Using mass analysis to monitor concentration of analytes in fluids; electrophilic and chromatographic separation
09/21/2010CA2420568C Pharmaceutically active benzsulfonamide derivatives as inhibitors of protein junkinases
09/16/2010WO2010077836A3 Pyrrolidine compounds which modulate the cb2 receptor
09/16/2010US20100234618 Process for the Preparation of Asenapine and Intermediate Products Used in Said Process
09/16/2010US20100234365 Compounds and compositions as inhibitors of cannabinoid receptor 1 activity
09/16/2010US20100234364 Ccr2 inhibitors and methods of use thereof
09/16/2010US20100234353 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
09/16/2010US20100234307 Preparation and use of biphenyl amino acid derivatives for the treatment of obesity
09/16/2010US20100233781 Tubular nanostructure targeted to cell membrane
09/16/2010US20100233190 Targeted polymeric prodrugs containing multifunctional linkers
09/16/2010US20100233106 Small-molecule modulators of melanin expression
09/15/2010CN101835873A Luminescent-element material and luminescent element
09/15/2010CN101835750A Cyclopropyl amide derivatives '978
09/15/2010CN101831486A Application of mycobacterium tuberculosis Rv1354c gene as medicament target
09/15/2010CN101830843A Substituted heterocyclic compound and synthetic method thereof
09/15/2010CN101830842A Preparation method of functional amino proline
09/14/2010US7795315 N-(2-amino-phenyl)-amide derivatives
09/14/2010US7795298 IAP BIR domain binding compounds
09/14/2010CA2422805C Retinoids for the treatment of emphysema
09/10/2010WO2010101246A1 Piperidine and pyrrolidine derivatives having npy y5 receptor antagonism
09/10/2010WO2010101118A1 Method of synthesizing [18f]sfb using microsynthesis technique
09/10/2010WO2010100238A1 Cross-linking agents
09/09/2010US20100228037 Process for Preparing Allylmercaptocaptopril (Cpssa) and Related Asymmetrical Disulfides
09/09/2010US20100228035 Functionalized Ionic Liquids, and Methods of Use Thereof
09/09/2010US20100228015 Prodrug derivatives of acids using alcohols with homotopic hydroxy groups and methods for their preparation and use
09/09/2010US20100227894 Benzamide factor viia inhibitors useful as anticoagulants
09/08/2010EP2226314A1 Cross-linking agents
09/08/2010EP2225196A1 Cysteine protease inhibitors for the treatment of parasitic diseases
09/08/2010EP1470106B1 Method of manufacturing an amorphous form of the hemi-calcium salt of (3r, 5r) 7- 3-phenyl-4-phenylcarbamoyl-2-(4-fluorophenyl)-5-isopropyl-pyrrol-1-yl]-3, 5-dihydroxyheptanoic acid (atorvastatin)
09/08/2010CN101823951A Process for the preparation of 2-ethyl-4,6-dimethylphenyl acetic acid
09/08/2010CN101048369B Biphenyloxyacetic acid derivatives for the treatment of respiratory disease
09/07/2010US7790719 used for the treatment of cachexia and other weight loss disorders, such as those resulting from cancer, HIV, old age and anorexia nervosa
09/07/2010CA2179935C Novel dipeptide compound or pharmaceutically acceptable salt thereof and medical use thereof
09/02/2010WO2010098351A1 Process for producing pyrrole compound
1 ... 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 ... 404